CDC Website CDC Website

To Join the NPIN community or

Home » HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

COVID-19 Information |

For COVID-19 testing information please visit: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Directly contact organizations to find out about changes to services or hours.

HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.

Letter of Intent Date
2/15/21
Application Due Date
3/15/21
Project Start Date
2/1/22
Application Contact
Madeline
Clarke
Grants Management Specialist
301-761-7794
Madeline.Clarke@nih.gov
Technical Contact
Bimal
Chakrabarti, Ph.D.
Scientific/Research Contact
sundstromj@niaid.nih.gov
240-627-3385
Fund Duration
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Subjects
Audiences

Fund Number: 

348492

Fund ID: 

PAR-21-024

Last modified: 

9/9/20